ATE350382T1 - Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden - Google Patents

Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden

Info

Publication number
ATE350382T1
ATE350382T1 AT04779031T AT04779031T ATE350382T1 AT E350382 T1 ATE350382 T1 AT E350382T1 AT 04779031 T AT04779031 T AT 04779031T AT 04779031 T AT04779031 T AT 04779031T AT E350382 T1 ATE350382 T1 AT E350382T1
Authority
AT
Austria
Prior art keywords
imidazopyrimidines
triazolopyrimidines
receptor ligands
benzodiazepine receptor
benzodiazepine
Prior art date
Application number
AT04779031T
Other languages
English (en)
Inventor
Linghong Xie
Bingsong Han
Yuelian Xu
George Maynard
Bertrand L Chenard
Kenneth Shaw
Yang Gao
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Application granted granted Critical
Publication of ATE350382T1 publication Critical patent/ATE350382T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04779031T 2003-07-25 2004-07-23 Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden ATE350382T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49000603P 2003-07-25 2003-07-25
US54308304P 2004-02-09 2004-02-09

Publications (1)

Publication Number Publication Date
ATE350382T1 true ATE350382T1 (de) 2007-01-15

Family

ID=34118813

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04779031T ATE350382T1 (de) 2003-07-25 2004-07-23 Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden

Country Status (21)

Country Link
US (2) US7271170B2 (de)
EP (1) EP1648899B1 (de)
JP (1) JP2007500130A (de)
KR (1) KR20060098425A (de)
AR (1) AR045117A1 (de)
AT (1) ATE350382T1 (de)
AU (1) AU2004261591A1 (de)
BR (1) BRPI0412908A (de)
CA (1) CA2537331A1 (de)
CY (1) CY1107565T1 (de)
DE (1) DE602004004143T2 (de)
DK (1) DK1648899T3 (de)
ES (1) ES2278345T3 (de)
HK (1) HK1089446A1 (de)
IL (1) IL173265A0 (de)
MX (1) MXPA06000887A (de)
NZ (1) NZ544262A (de)
PL (1) PL1648899T3 (de)
PT (1) PT1648899E (de)
TW (1) TW200524937A (de)
WO (1) WO2005012306A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
WO2004107863A1 (en) * 2003-05-05 2004-12-16 Neurogen Corporation Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands
WO2006093911A2 (en) * 2005-03-02 2006-09-08 Neurogen Corporation Thiazolylmethyl and oxazolylmethyl heteroaryl derivatives
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles
EP2146576A4 (de) * 2007-04-11 2013-01-16 Cypress Bioscience Inc Behandlung von down-syndrom mit benzodiazepinreaktorantagonisten
WO2008130951A1 (en) * 2007-04-17 2008-10-30 Bristol-Myers Squibb Company Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
US20090270373A1 (en) * 2008-04-11 2009-10-29 Cypress Biosciences, Inc. Treatment of down syndrom with benzodiazepine receptor antagonists

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544057A (en) * 1895-08-06 Bill and letter file
AU4058000A (en) * 1999-04-02 2000-10-23 Neurogen Corporation Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulatorsof gabaa receptors
US6737242B1 (en) 1999-05-07 2004-05-18 Neurogen Corporation Methods for screening GABA-modulatory compounds for specified pharmacological activities
GB9929687D0 (en) * 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents
WO2002002557A2 (en) 2000-06-30 2002-01-10 Neurogen Corporation 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands
GB0027561D0 (en) * 2000-11-10 2000-12-27 Merck Sharp & Dohme Therapeutic agents
US6900215B2 (en) * 2000-12-15 2005-05-31 Merck Sharp & Dohme Ltd. Imidazo-pyrimidine derivatives as ligands for gaba receptors
PA8535601A1 (es) * 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
TWI248936B (en) * 2001-03-21 2006-02-11 Merck Sharp & Dohme Imidazo-pyrimidine derivatives as ligands for GABA receptors
ATE338758T1 (de) * 2001-03-23 2006-09-15 Merck Sharp & Dohme Imidazopyrimidin-derivate als liganden für gaba- rezeptoren
IL159811A0 (en) * 2001-07-13 2004-06-20 Neurogen Corp Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
GB0128499D0 (en) * 2001-11-28 2002-01-23 Merck Sharp & Dohme Therapeutic agents
US7030144B2 (en) 2002-05-02 2006-04-18 Neurogen Corporation Substituted imidazole derivatives: GABAA receptor ligands
US6982268B2 (en) 2002-05-08 2006-01-03 Neurogen Corporation Substituted imidazolylmethyl pyridine and pyrazine derivatives GABAA receptor ligands
ES2273008T3 (es) 2002-05-17 2007-05-01 Neurogen Corporation Derivados de imidazol con anillos fusionados sustituidos: ligandos de receptores gaba sba/sb.
CN100579579C (zh) 2002-10-01 2010-01-13 诺华疫苗和诊断公司 抗癌及抗感染性疾病组合物及其使用方法
WO2004041808A1 (en) 2002-11-08 2004-05-21 Neurogen Corporation 4-imidazol-1-ylmethyl-pyrimidine derivatives_as ligands for gabaa receptors
WO2004107863A1 (en) 2003-05-05 2004-12-16 Neurogen Corporation Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands

Also Published As

Publication number Publication date
AU2004261591A1 (en) 2005-02-10
DE602004004143T2 (de) 2007-10-11
TW200524937A (en) 2005-08-01
HK1089446A1 (en) 2006-12-01
US20080139580A1 (en) 2008-06-12
EP1648899A2 (de) 2006-04-26
CY1107565T1 (el) 2013-03-13
DE602004004143D1 (de) 2007-02-15
BRPI0412908A (pt) 2006-09-26
JP2007500130A (ja) 2007-01-11
US20050038043A1 (en) 2005-02-17
WO2005012306A3 (en) 2005-04-14
WO2005012306A2 (en) 2005-02-10
AR045117A1 (es) 2005-10-19
IL173265A0 (en) 2006-06-11
PT1648899E (pt) 2007-03-30
DK1648899T3 (da) 2007-04-02
NZ544262A (en) 2009-06-26
KR20060098425A (ko) 2006-09-18
CA2537331A1 (en) 2005-02-10
EP1648899B1 (de) 2007-01-03
US7271170B2 (en) 2007-09-18
ES2278345T3 (es) 2007-08-01
PL1648899T3 (pl) 2007-06-29
MXPA06000887A (es) 2006-04-19

Similar Documents

Publication Publication Date Title
EP1734820A4 (de) Imidazopyrazine, imidazopyridine und imidazopyrimidine als crf1-rezeptorliganden
NO20055510D0 (no) 2-alkynyl- og 2-alkenylpyrazolo [4,3-E]-1,2,4-triazolo-[1,5-C]-pyrimidin-adenosin A2A-reseptorantagonister
DE60104671D1 (de) Imidazopyrimidin-derivate und triazolopyrimidin-derivate
NO20053955D0 (no) Pyrazolo [1,5-A] pyrimidinderivater
DK1699795T3 (da) Substituerede 8'-pyri(mi)dinyldihydrospiro[cycloalkylamin]-pyrimido[1,2-a]pyrimidin-6-onderivater
IL180757A0 (en) Imidazo[4,5-d] pyrimidines, their uses and methods of preparation
HK1095818A1 (en) Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine-a2a-receptor antagonists
IL174512A0 (en) Pyrazolo and imidazo-pyrimidine derivatives
GB0416511D0 (en) Pyrrolobenzodiazepines
IL183110A0 (en) Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
NO20054330D0 (no) 8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
DE50302207D1 (de) Alkyl-substituierte pyrazolopyrimidine
NO20054331D0 (no) Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
IL177510A0 (en) Pyrazolopyrimidines
IL175915A0 (en) Substituted imidazo ring systems and methods
ZA200606615B (en) Heteroaryl-fused pyrazolo derivatives
IL172098A0 (en) Triazolopyrimidines
ZA200510276B (en) Triazolopyrimidines
DE50208341D1 (de) Triazolopyrimidine
DE502004011106D1 (de) 6-arylmethyl-substituierte pyrazolopyrimidine
DE60103909D1 (de) 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
HK1089446A1 (en) Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
DE602004004295T8 (de) 6-[(Substituiertes)]Triazolopyrimidine als Antikrebsmittel
PL372989A1 (en) Triazolopyrimidines
IL177856A0 (en) 2-pyridinyl[7-(substituted-pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1648899

Country of ref document: EP

REN Ceased due to non-payment of the annual fee